Clinical Research in Cardiology

, Volume 97, Issue 12, pp 851–864

Clinical trial updates and hotline sessions presented at the European Society of Cardiology Congress 2008

  • Patrick Müller
  • Stephan Rosenkranz
  • Oliver Adam
  • Florian Custodis
  • Michael Böhm
CLINICAL TRIAL UPDATES AND HOTLINE SESSIONS

DOI: 10.1007/s00392-008-0729-7

Cite this article as:
Müller, P., Rosenkranz, S., Adam, O. et al. Clin Res Cardiol (2008) 97: 851. doi:10.1007/s00392-008-0729-7

Abstract

This article summarizes the results of a number of clinical trials in the field of cardiovascular medicine which were presented during the Hotline and Clinical Trial Update Sessions at the annual meeting of the European Society of Cardiology, held in Munich, Germany, from 30th August to 3rd September 2008. The data were presented by leading experts in the field with relevant positions in the trials. It is important to note that unpublished reports should be considered as preliminary data, as the analysis may change in the final publications. The comprehensive summaries have been generated from the oral presentation and the webcasts of the European Society of Cardiology and should provide the readers with the most comprehensive information on diagnostic and therapeutic developments in cardiovascular medicine.

Keywords

PIHRATE HORIZONS AMI regent 3T/2R APPRAISE-I SYNTAX CARDia IBIS II DECREASE III BEAUTIFUL TIME-CHF TIMIC ONTARGET TRANSCEND GISSI-HF ATHENA SEAS 

Abbreviations

3-VD

Three vessel disease

ACS

Acute coronary syndrome

ACE-I

Angiotensin converting enzyme inhibitor

AF

Atrial fibrillation

AFL

Atrial flutter

BP

Blood pressure

bpm

Beats per minute

CABG

Coronary artery bypass grafting

CAD

Coronary artery disease

CHF

Congestive heart failure

CI

Confidence interval

CRP

C-reactive protein

DES

Drug eluting stents

ECG

Electrocardiogram

ESC

European Society of Cardiology

GPIIb/IIIa

Glycoprotein IIb IIIa

HR

Hazard ratio

LDL

Low density lipoprotein

LM

Left main coronary artery

LVEF

Left ventricular ejection fraction

MACE

Major adverse cardiovascular events

MBG

Myocardial blush grade

MI

Myocardial infarction

MRI

Magnetic resonance imaging

NNT

Number needed to treat

NS

Not significant

NSTE-ACS

Non-ST-segment elevation acute coronary syndrome

NSTEMI

Non-ST-segment elevation myocardial infarction

NYHA

New York Heart Association

OR

Odds ratio

PCI

Percutaneous coronary intervention

RR

Relative risk

STEMI

ST-segment elevation myocardial infarction

STR

ST segment elevation resolution

TVR

Target vessel revascularization

TIMI

Thrombolysis in myocardial infarction group

UFH

Unfractionated heparin

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Patrick Müller
    • 1
  • Stephan Rosenkranz
    • 1
  • Oliver Adam
    • 1
  • Florian Custodis
    • 1
  • Michael Böhm
    • 1
  1. 1.Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische IntensivmedizinUniversitätsklinikum des SaarlandesHomburg/SaarGermany

Personalised recommendations